| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,559 |
35,822 |
$2.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,341 |
3,007 |
$171K |
| 99205 |
Prolong outpt/office vis |
210 |
187 |
$23K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
308 |
284 |
$20K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
289 |
277 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,537 |
1,336 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
328 |
291 |
$17K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
274 |
242 |
$14K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
183 |
164 |
$11K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
464 |
413 |
$6K |
| 94060 |
|
187 |
177 |
$6K |
| 90756 |
|
423 |
348 |
$5K |
| 90688 |
|
412 |
369 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,122 |
880 |
$3K |
| 90674 |
|
132 |
127 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$1K |
| 92551 |
|
370 |
343 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
256 |
74 |
$1K |
| 99173 |
|
372 |
345 |
$671.02 |
| 0011A |
|
26 |
19 |
$407.88 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
698 |
579 |
$132.58 |
| 93000 |
|
15 |
13 |
$132.44 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
707 |
594 |
$26.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$16.05 |
| 3017F |
|
45 |
39 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
204 |
189 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
67 |
63 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
109 |
103 |
$0.00 |
| 90686 |
|
71 |
63 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
29 |
28 |
$0.00 |
| 91301 |
|
27 |
20 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
52 |
45 |
$0.00 |
| 1006F |
|
17 |
15 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
91 |
84 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
53 |
51 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
349 |
292 |
$0.00 |
| 4040F |
|
109 |
100 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
188 |
166 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
184 |
162 |
$0.00 |
| 90734 |
|
28 |
24 |
$0.00 |
| 90670 |
|
60 |
53 |
$0.00 |
| 90633 |
|
15 |
15 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
108 |
103 |
$0.00 |
| 1124F |
|
95 |
87 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
13 |
12 |
$0.00 |